Capra Biosciences: Funding, Investors & Team (Sep 2026)
Capra Biosciences is a biotechnology organization bridling science for effective and low-carbon creation of regular synthetics. It creates bioreactor innovation intended to make the development of synthetic items more productive. The organization fostered a biofilm bioreactor which can possibly fundamentally decrease the downstream handling necessities and expenses innate in the bio-assembling of items like powers. Capra Biosciences was established in 2020 and is settled in Alexandria, VA.
Capra Biosciences has raised $7.2M across 3 funding rounds on record, the most recent a Seed of $3.4M announced in Dec 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Capra Biosciences Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Capra Biosciences Funding Rounds
Capra Biosciences raised $1.8M in a Pre-Seed announced in Jun 2022.
10 months later, an undisclosed round of $2.0M was announced in Apr 2023.
8 months later, a Seed of $3.4M was announced in Dec 2023.
Capra Biosciences Founders and Leadership Team
Contact details for the Capra Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Capra Biosciences Funding Compared to Other Biotechnology Startups
Capra Biosciences' latest round of $3.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Capra Biosciences in Biotechnology and Alexandria
Companies Similar to Capra Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Capra Biosciences Funding FAQs
What does Capra Biosciences do?
Capra Biosciences is a biotechnology organization bridling science for effective and low-carbon creation of regular synthetics. It creates bioreactor innovation intended to make the development of synthetic items more productive. The organization fostered a biofilm bioreactor which can possibly fundamentally decrease the downstream handling necessities and expenses innate in the bio-assembling of items like powers. Capra Biosciences was established in 2020 and is settled in Alexandria, VA.
How much funding has Capra Biosciences raised?
Capra Biosciences has raised $7.2M across 3 rounds on record. The most recent is a Seed of $3.4M announced in Dec 2023.
When did Capra Biosciences last raise funding?
Capra Biosciences' most recent funding round on record is a Seed of $3.4M, announced in Dec 2023.
Who founded Capra Biosciences?
FundedIQ lists Andrew Magyar (Founder) at Capra Biosciences.
Where is Capra Biosciences headquartered?
Capra Biosciences is based in Alexandria, Virginia, United States.
How many employees does Capra Biosciences have?
Capra Biosciences is in the 1-10 employee band.
How does Capra Biosciences' funding compare to other Biotechnology startups?
Capra Biosciences' latest round of $3.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Capra Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Capra Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.